Charting roadmaps towards novel and safe synergistic immunotherapy combinations
Miguel F Sanmamed1,2,3,4, Pedro Berraondo1,2,4, Maria E Rodriguez-Ruiz1,2,3
1Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
Nature Cancer
|June 28, 2022
Summary
Combining cancer immunotherapies with other treatments shows promise for better efficacy. Optimizing these combinations is crucial for prioritizing synergistic therapies and identifying biomarkers for improved cancer care.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Checkpoint inhibitor immunotherapy is frequently combined with other treatments like targeted therapies and chemotherapy.
- Numerous immunotherapy combinations are in clinical trials, requiring careful evaluation.
Purpose of the Study:
- To review recent advancements in cancer immunotherapy combinations.
- To discuss strategies for optimizing these combinations for maximum clinical impact.
Main Methods:
- Review of current clinical research on immunotherapy combinations.
- Analysis of criteria for prioritizing synergistic, safe, and effective combination therapies.
Main Results:
- The need for robust criteria to select optimal immunotherapy combinations.
- Importance of identifying biomarkers for therapy response and resistance.
Conclusions:
- Optimizing immunotherapy combinations is key to advancing cancer treatment.
- Further research is needed to establish best practices for combination therapy sequencing and patient selection.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:27Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
01:30Cancer Vaccines
506
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
506
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K